SYM FINANCIAL Corp Invests $1.12 Million in Intuitive Surgical, Inc. (NASDAQ:ISRG)

SYM FINANCIAL Corp purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the first quarter, according to its most recent filing with the SEC. The firm purchased 2,261 shares of the medical equipment provider's stock, valued at approximately $1,120,000.

A number of other hedge funds have also modified their holdings of ISRG. Brighton Jones LLC grew its stake in shares of Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock valued at $1,916,000 after buying an additional 731 shares during the period. Bank Pictet & Cie Europe AG grew its stake in shares of Intuitive Surgical by 0.5% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock valued at $99,678,000 after buying an additional 883 shares during the period. Hillsdale Investment Management Inc. grew its stake in shares of Intuitive Surgical by 40.1% during the 4th quarter. Hillsdale Investment Management Inc. now owns 699 shares of the medical equipment provider's stock valued at $365,000 after buying an additional 200 shares during the period. Modern Wealth Management LLC grew its stake in shares of Intuitive Surgical by 15.1% during the 4th quarter. Modern Wealth Management LLC now owns 1,036 shares of the medical equipment provider's stock valued at $541,000 after buying an additional 136 shares during the period. Finally, Princeton Capital Management LLC purchased a new stake in shares of Intuitive Surgical during the 4th quarter valued at $212,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on ISRG. UBS Group lifted their target price on shares of Intuitive Surgical from $547.00 to $585.00 and gave the company a "neutral" rating in a report on Wednesday. Robert W. Baird cut their price objective on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. BTIG Research boosted their price objective on shares of Intuitive Surgical from $566.00 to $571.00 and gave the stock a "buy" rating in a report on Wednesday. Erste Group Bank reiterated a "hold" rating on shares of Intuitive Surgical in a report on Wednesday. Finally, Wall Street Zen upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Saturday. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average target price of $592.05.

Intuitive Surgical Stock Up 1.5%

Intuitive Surgical stock traded up $7.25 during midday trading on Friday, hitting $495.86. 1,870,941 shares of the stock were exchanged, compared to its average volume of 1,842,693. The company has a fifty day simple moving average of $529.86 and a two-hundred day simple moving average of $535.13. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The stock has a market capitalization of $177.73 billion, a PE ratio of 69.16, a P/E/G ratio of 5.45 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm's revenue for the quarter was up 21.4% on a year-over-year basis. During the same period in the previous year, the company earned $1.78 earnings per share. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Robert Desantis sold 188 shares of the firm's stock in a transaction that occurred on Monday, April 28th. The shares were sold at an average price of $515.91, for a total value of $96,991.08. Following the completion of the transaction, the executive vice president owned 5,224 shares in the company, valued at $2,695,113.84. This trade represents a 3.47% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Jami K. Nachtsheim sold 2,400 shares of the firm's stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the transaction, the director owned 6,371 shares of the company's stock, valued at approximately $3,312,920. This trade represents a 27.36% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 7,798 shares of company stock valued at $3,955,331. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.